Skip to Content

Thyroid medications recalled

Screen Shot 2020-09-21 at 6.33.42 AM
FDA

Four people reported problems

(KYMA, KECY) - Two types of thyroid medication are recalled by the manufacturer after four people reported having adverse effects.

The U.S. Food and Drug Administration (FDA) said NP Thyroid tablets made by Acella Pharmaceuticals, LLC health problems with heart issues were associated with the recalled drugs.

The company issued a statement saying, "Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found these lots to be sub potent. The product may have as low as 87% of the labeled amount of levothyroxine (T4)."

Here are the recalled product details:

  • NP Thyroid 15, Thyroid Tablets, USP, ¼ grain (15 mg), NDC No. 42192-327-01, Lot No. M327E19-1, expiration date October 2020
  • NP Thyroid 120, Thyroid Tablets, USP, 2 grain (120 mg), NDC No. 42192-328-01, Lot No. M328F19-3, expiration date November 2020.

Click here to read FDA's full statement.

Article Topic Follows: News

Jump to comments ↓

Author Profile Photo

Sumiko Keil

Sumiko Keil has served as the Digital Content Producer since March 2019.

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content